Clinical Trial Update: Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism [Phase 3]

View source ↗

Summary

Phase 3 trial comparing paricalcitol injections with maxacalcitol injections in adult Japanese CKD patients on hemodialysis with secondary hyperparathyroidism; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Maxacalcitol (maxacalcitol)
• Zemplar (Paricalcitol)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Secondary Hyperparathyroidism, Hemodialysis | Phase 3 | Status: COMPLETED | Results posted: 2013-06-06